091970 — Nano Chem Tech Balance Sheet
0.000.00%
- KR₩22bn
- KR₩46bn
- KR₩56bn
- 17
- 64
- 20
- 22
Annual balance sheet for Nano Chem Tech, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17,725 | 33,301 | 8,277 | 7,168 | 4,835 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 15,787 | 10,957 | 8,943 | 13,455 | 11,533 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 38,503 | 50,783 | 24,618 | 27,487 | 21,096 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 22,195 | 21,074 | 18,985 | 18,791 | 21,005 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 72,033 | 80,811 | 47,019 | 54,793 | 73,006 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 12,528 | 35,583 | 17,583 | 22,699 | 26,346 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 13,685 | 36,176 | 18,877 | 22,850 | 44,444 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 58,349 | 44,635 | 28,142 | 31,943 | 28,562 |
Total Liabilities & Shareholders' Equity | 72,033 | 80,811 | 47,019 | 54,793 | 73,006 |
Total Common Shares Outstanding |